This is a well-structured M&A case that requires candidates to quickly recognize that a fragmented, low-margin regional healthcare market signals consolidation opportunity. The case tests both quantitative analysis (margin calculations, synergy quantification) and strategic reasoning (why merge with System #3 rather than alternatives). Strong candidates should identify the importance of scale early and avoid getting trapped in non-material cost reduction initiatives like pricing.